logo
Select company
Select metric
-13620.27%Operating Cash Flow Margin
VS
Market
1
Sector
4
Industry
8
History
-
$ 26.76Close
$ 21.77 - $ 66.83 52-Week Range
Ticker Information

Ticker

JANX

Company Name

JANUX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

JANUX THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

JANX - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -59.79M-13620.27%$ 439K
3/31/2025$ -46M-492.73%$ 9.34M
12/31/2024$ -43.81M-413.81%$ 10.59M
9/30/2024$ -36.99M-283.47%$ 13.05M
6/30/2024$ -46.47M-307.19%$ 15.13M
3/31/2024$ -51.5M-706.75%$ 7.29M
12/31/2023$ -50.58M-625.7%$ 8.08M
9/30/2023$ -52.59M-621.08%$ 8.47M
6/30/2023$ -54.29M-699.37%$ 7.76M
3/31/2023$ -45.31M-499.51%$ 9.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • JANUX THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -466.76%.
  • Over the past 5 years, JANUX THERAPEUTICS INC's average OCF % has been -1400.27%.
  • The median OCF % for JANUX THERAPEUTICS INC during this period was -504.24%
  • JANUX THERAPEUTICS INC reached its highest OCF % over the past 5 years at -283.47%.
  • The lowest OCF % recorded by JANUX THERAPEUTICS INC in the same timeframe -13620.27%

JANUX THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
VRDN : VIRIDIAN THERAPEUTICS INC -101332.46%CGON : CG ONCOLOGY INC -17026.68%PROK : PROKIDNEY CORP -21711.57%ABEO : ABEONA THERAPEUTICS INC -16494.75%AVTX : AVALO THERAPEUTICS INC -10752.38%MREO : MEREO BIOPHARMA GROUP PLC -6583.8%COYA : COYA THERAPEUTICS INC -3890.1%ETNB : 89BIO INC -EWTX : EDGEWISE THERAPEUTICS INC -DYN : DYNE THERAPEUTICS INC -

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for JANUX THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -16.98M ] / Revenues [ $ 3.64M ]
(=) OCF % [ -466.76% ]

JANX - Operating Cash Flow Margin, Last 5 years

-13620.27%

Minimum

Jun 30, 2025

-283.47%

Maximum

Sep 30, 2024

-1400.27%

Average

-504.24%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%